Published in Mutagenesis on January 01, 1999
Focal adhesion size uniquely predicts cell migration. FASEB J (2012) 1.40
Predicting how cells spread and migrate: focal adhesion size does matter. Cell Adh Migr (2013) 0.88
Chromosome instability and risk of squamous cell carcinomas of head and neck. Cancer Res (2008) 0.82
Combined cytogenotoxic effects of bee venom and bleomycin on rat lymphocytes: an in vitro study. Biomed Res Int (2014) 0.75
Cervical lymph node metastasis: assessment of radiologic criteria. Radiology (1990) 3.24
Phase 3 randomized trial on larynx preservation comparing sequential vs alternating chemotherapy and radiotherapy. J Natl Cancer Inst (2009) 2.83
The additional value of chemotherapy to radiotherapy in locally advanced nasopharyngeal carcinoma: a meta-analysis of the published literature. J Clin Oncol (2004) 2.63
Genome-wide DNA copy number alterations in head and neck squamous cell carcinomas with or without oncogene-expressing human papillomavirus. Oncogene (2006) 2.56
The size of lymph nodes in the neck on sonograms as a radiologic criterion for metastasis: how reliable is it? AJNR Am J Neuroradiol (1998) 2.48
Recurrence at the primary site in head and neck cancer and the significance of neck lymph node metastases as a prognostic factor. Cancer (1994) 1.98
Regional lymph node involvement and its significance in the development of distant metastases in head and neck carcinoma. Cancer (1993) 1.82
Biological evidence that human papillomaviruses are etiologically involved in a subgroup of head and neck squamous cell carcinomas. Int J Cancer (2001) 1.82
Human papillomavirus detection and comorbidity: critical issues in selection of patients with oropharyngeal cancer for treatment De-escalation trials. Ann Oncol (2013) 1.77
Inherited susceptibility to bleomycin-induced chromatid breaks in cultured peripheral blood lymphocytes. J Natl Cancer Inst (1999) 1.68
Prognostic factors of neck node metastasis. Clin Otolaryngol Allied Sci (1982) 1.67
Correlating MRI and clinical disease activity in multiple sclerosis: relevance of hypointense lesions on short-TR/short-TE (T1-weighted) spin-echo images. Neurology (1995) 1.63
Persistence of genetically altered fields in head and neck cancer patients: biological and clinical implications. Clin Cancer Res (2001) 1.60
The impact of nutritional status on the prognoses of patients with advanced head and neck cancer. Cancer (1999) 1.53
Prevalence of depression in cancer patients: a meta-analysis of diagnostic interviews and self-report instruments. Psychooncology (2013) 1.53
Phase I therapy study of 186Re-labeled chimeric monoclonal antibody U36 in patients with squamous cell carcinoma of the head and neck. J Nucl Med (2000) 1.52
A review on re-irradiation for recurrent and second primary head and neck cancer. Oral Oncol (2004) 1.52
The human E48 antigen, highly homologous to the murine Ly-6 antigen ThB, is a GPI-anchored molecule apparently involved in keratinocyte cell-cell adhesion. J Cell Biol (1995) 1.51
Interaction between cisplatin and gemcitabine in vitro and in vivo. Semin Oncol (1995) 1.49
The survival of patients with inoperable lung cancer: a large-scale randomized study of radiation therapy versus placebo. Radiology (1968) 1.48
Screening for distant metastases in patients with head and neck cancer. Laryngoscope (2000) 1.42
Potential early markers of carcinogenesis in the mucosa of the head and neck using exfoliative cytology. J Pathol (1996) 1.42
[Development and results of surgical treatment of pleomorphic adenoma of the parotid gland in 245 patients, 1974-1994]. Ned Tijdschr Geneeskd (1996) 1.39
Total glossectomy with laryngeal preservation. Arch Otolaryngol Head Neck Surg (1993) 1.38
[Diagnosis of lymph node metastasis of head-neck carcinomas]. Ned Tijdschr Geneeskd (1995) 1.38
Modern imaging techniques and ultrasound-guided aspiration cytology for the assessment of neck node metastases: a prospective comparative study. Eur Arch Otorhinolaryngol (1993) 1.37
Primary extranodal non-Hodgkin lymphoma of the oral cavity. An analysis of 34 cases. Eur J Cancer B Oral Oncol (1994) 1.31
The costs of head and neck oncology: primary tumours, recurrent tumours and long-term follow-up. Eur J Cancer (2001) 1.31
Metastasizing ameloblastoma. Int J Oral Maxillofac Surg (2007) 1.31
Prevalence and expression of human papillomavirus in tonsillar carcinomas, indicating a possible viral etiology. Int J Cancer (1992) 1.24
Surgical management of 246 previously untreated pleomorphic adenomas of the parotid gland. Br J Surg (1997) 1.22
Standardization of counting micronuclei: definition of a protocol to measure genotoxic damage in human exfoliated cells. Carcinogenesis (1995) 1.21
Targeting of aluminum (III) phthalocyanine tetrasulfonate by use of internalizing monoclonal antibodies: improved efficacy in photodynamic therapy. Cancer Res (2001) 1.19
Lymph node staging in patients with clinically negative neck examinations by ultrasound and ultrasound-guided aspiration cytology. Am J Surg (1991) 1.18
p53 expression above the basal cell layer in oral mucosa is an early event of malignant transformation and has predictive value for developing oral squamous cell carcinoma. J Pathol (1998) 1.18
Psychotropic medication in children: a study from the Netherlands. Pediatrics (2001) 1.18
The incidence of micrometastases in neck dissection specimens obtained from elective neck dissections. Laryngoscope (1996) 1.16
Parapharyngeal tumours: a review of 23 cases. Clin Otolaryngol Allied Sci (1989) 1.15
Delay in diagnosis of oral squamous cell carcinoma; a report from The Netherlands. Eur J Cancer B Oral Oncol (1992) 1.14
Squamous cell carcinoma of maxillary sinus. Head Neck (2000) 1.14
Joint practice guidelines for radionuclide lymphoscintigraphy for sentinel node localization in oral/oropharyngeal squamous cell carcinoma. Ann Surg Oncol (2009) 1.14
Development of meta-tetrahydroxyphenylchlorin-monoclonal antibody conjugates for photoimmunotherapy. Cancer Res (1999) 1.14
Critical weight loss is a major prognostic indicator for disease-specific survival in patients with head and neck cancer receiving radiotherapy. Br J Cancer (2013) 1.14
False-positive and false-negative neck nodes. Head Neck Surg (1986) 1.13
Effect of chemotherapy on survival of craniofacial osteosarcoma: a systematic review of 201 patients. J Clin Oncol (1997) 1.11
Labeling of monoclonal antibodies with rhenium-186 using the MAG3 chelate for radioimmunotherapy of cancer: a technical protocol. J Nucl Med (1993) 1.10
The library consortium -- service for community hospitals in Georgia. J Med Assoc Ga (1980) 1.10
Touch screen computer-assisted health-related quality of life and distress data collection in head and neck cancer patients. Clin Otolaryngol (2008) 1.10
Role of genetic factors in the etiology of squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg (1995) 1.09
Age-dependence of human papillomavirus DNA presence in oral squamous cell carcinomas. Eur J Cancer B Oral Oncol (1996) 1.08
Assessment of malnutrition parameters in head and neck cancer and their relation to postoperative complications. Head Neck (1997) 1.08
Histological reclassification of 101 intraoral salivary gland tumours (new WHO classification). J Clin Pathol (1992) 1.08
Epirubicin in patients with advanced or recurrent adenoid cystic carcinoma of the head and neck: a phase II study of the EORTC Head and Neck Cancer Cooperative Group. Ann Oncol (1993) 1.07
The surgical management of recurrent or residual pleomorphic adenomas of the parotid gland. Analysis and results in 40 patients. Eur Arch Otorhinolaryngol (1997) 1.06
Occult metastatic neck disease: detection with US and US-guided fine-needle aspiration cytology. Radiology (1991) 1.06
Genetic susceptibility to head and neck squamous cell carcinoma. J Natl Cancer Inst (1996) 1.04
Phase II preclinical drug screening in human tumor xenografts: a first European multicenter collaborative study. Cancer Res (1992) 1.04
Severe radiation injuries of the stomach, small intestine, colon and rectum. Am J Roentgenol Radium Ther Nucl Med (1972) 1.04
Mucosal melanomas of the head and neck. Otolaryngol Clin North Am (1986) 1.03
TP53 mutation and human papilloma virus status of oral squamous cell carcinomas in young adult patients. Oral Dis (2013) 1.02
Coexistence of widespread clones and large radial clones in early embryonic ferret cortex. Cereb Cortex (1999) 1.02
Effect of perioperative nutrition, with and without arginine supplementation, on nutritional status, immune function, postoperative morbidity, and survival in severely malnourished head and neck cancer patients. Am J Clin Nutr (2001) 1.02
Preclinical phase II studies in human tumor xenografts: a European multicenter follow-up study. Ann Oncol (1994) 1.00
Results of the surgical management and histopathological evaluation of 88 parotid gland Warthin's tumours. Clin Otolaryngol Allied Sci (1997) 1.00
Centromeric breakage as a major cause of cytogenetic abnormalities in oral squamous cell carcinoma. Genes Chromosomes Cancer (1996) 1.00
Lack of appropriate formulations of medicines for children in the community. Acta Paediatr (2003) 1.00
Molecular assays for the diagnosis of minimal residual head-and-neck cancer: methods, reliability, pitfalls, and solutions. Clin Cancer Res (2000) 1.00
A 22-kd surface antigen detected by monoclonal antibody E 48 is exclusively expressed in stratified squamous and transitional epithelia. Am J Pathol (1990) 0.99
Intracranial metastases in patients with squamous cell carcinoma of the head and neck. Otolaryngol Head Neck Surg (2001) 0.99
Current treatment options for local residual nasopharyngeal carcinoma. Curr Treat Options Oncol (2013) 0.99
Monoclonal antibodies labeled with rhenium-186 using the MAG3 chelate: relationship between the number of chelated groups and biodistribution characteristics. J Nucl Med (1996) 0.98
Management of cervical lymph nodes in patients with head and neck cancer. Eur Arch Otorhinolaryngol (1992) 0.98
Parotid gland tumors: histologic reevaluation and reclassification of 478 cases. Head Neck (1998) 0.98
Production of a monoclonal antibody (K 931) to a squamous cell carcinoma associated antigen identified as the 17-1A antigen. Hybridoma (1990) 0.98
Squamous cell carcinoma arising in the lining of odontogenic cysts. Report of 5 cases. Int J Oral Surg (1985) 0.98
Positive surgical margins in neck dissection specimens in patients with head and neck squamous cell carcinoma and the effect of radiotherapy. Head Neck (2000) 0.98
Human papillomavirus (HPV) type 16 and 33 E6/E7 region transcripts in tonsillar carcinomas can originate from integrated and episomal HPV DNA. J Gen Virol (1992) 0.97
T3 laryngeal cancer: a retrospective study of the Dutch Head and Neck Oncology Cooperative Group: study design and general results. Clin Otolaryngol Allied Sci (1992) 0.97
Malignant epithelial parotid gland tumours: analysis and results in 65 previously untreated patients. Br J Surg (1998) 0.97
Immunosuppressive retroviral P15E-related factors in head and neck carcinomas. Arch Otolaryngol Head Neck Surg (1986) 0.96
High dose rhenium-186-labeling of monoclonal antibodies for clinical application: pitfalls and solutions. Cancer (1997) 0.96
Defective monocyte chemotaxis in patients with head and neck cancer. Restoration after treatment. Arch Otolaryngol Head Neck Surg (1986) 0.95
The efficacy of comprehensive neck dissection with or without postoperative radiotherapy in nodal metastases of squamous cell carcinoma of the upper respiratory and digestive tracts. Laryngoscope (1990) 0.95
Localization and imaging of radiolabelled monoclonal antibody against squamous-cell carcinoma of the head and neck in tumor-bearing nude mice. Int J Cancer (1989) 0.95